-
1
-
-
21844442166
-
Methods to avoid infections in patients with inflammatory bowel disease
-
Aberra F.N., and Lichtenstein G.R. Methods to avoid infections in patients with inflammatory bowel disease. Inflamm Bowel Dis 11 (2005) 685-695
-
(2005)
Inflamm Bowel Dis
, vol.11
, pp. 685-695
-
-
Aberra, F.N.1
Lichtenstein, G.R.2
-
3
-
-
0043033175
-
Corticosteroids and immunomodulators: postoperative infectious complication risk in inflammatory bowel disease patients
-
Aberra F.N., Lewis J.D., Hass D., et al. Corticosteroids and immunomodulators: postoperative infectious complication risk in inflammatory bowel disease patients. Gastroenterology 125 (2003) 320-327
-
(2003)
Gastroenterology
, vol.125
, pp. 320-327
-
-
Aberra, F.N.1
Lewis, J.D.2
Hass, D.3
-
4
-
-
23244444498
-
Infectious complications of percutaneous vascular closure devices
-
Sohail M.R., Khan A.H., Holmes Jr. D.R., et al. Infectious complications of percutaneous vascular closure devices. Mayo Clin Proc 80 (2005) 1011-1015
-
(2005)
Mayo Clin Proc
, vol.80
, pp. 1011-1015
-
-
Sohail, M.R.1
Khan, A.H.2
Holmes Jr., D.R.3
-
5
-
-
11144357651
-
The risk of post-operative complications associated with infliximab therapy for Crohn's disease: a controlled cohort study
-
Marchal L., D'Haens G., Van Assche G., et al. The risk of post-operative complications associated with infliximab therapy for Crohn's disease: a controlled cohort study. Aliment Pharmacol Ther 19 (2004) 749-754
-
(2004)
Aliment Pharmacol Ther
, vol.19
, pp. 749-754
-
-
Marchal, L.1
D'Haens, G.2
Van Assche, G.3
-
6
-
-
0037292855
-
Infection complications associated with the use of biologic agents
-
Bresnihan B., and Cunnane G. Infection complications associated with the use of biologic agents. Rheum Dis Clin North Am 29 (2003) 185-202
-
(2003)
Rheum Dis Clin North Am
, vol.29
, pp. 185-202
-
-
Bresnihan, B.1
Cunnane, G.2
-
7
-
-
22844439662
-
Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis
-
Kleinschmidt-DeMasters B.K., and Tyler K.L. Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis. N Engl J Med 353 (2005) 369-374
-
(2005)
N Engl J Med
, vol.353
, pp. 369-374
-
-
Kleinschmidt-DeMasters, B.K.1
Tyler, K.L.2
-
8
-
-
22844445230
-
Progressive multifocal leukoencephalopathy in a patient treated with natalizumab
-
Langer-Gould A., Atlas S.W., Green A.J., et al. Progressive multifocal leukoencephalopathy in a patient treated with natalizumab. N Engl J Med 353 (2005) 375-381
-
(2005)
N Engl J Med
, vol.353
, pp. 375-381
-
-
Langer-Gould, A.1
Atlas, S.W.2
Green, A.J.3
-
9
-
-
22844445587
-
Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease
-
Van Assche G., Van Ranst M., Sciot R., et al. Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease. N Engl J Med 353 (2005) 362-368
-
(2005)
N Engl J Med
, vol.353
, pp. 362-368
-
-
Van Assche, G.1
Van Ranst, M.2
Sciot, R.3
-
10
-
-
0036682163
-
Clinical practice. Herpes zoster
-
Gnann Jr. J.W., and Whitley R.J. Clinical practice. Herpes zoster. N Engl J Med 347 (2002) 340-346
-
(2002)
N Engl J Med
, vol.347
, pp. 340-346
-
-
Gnann Jr., J.W.1
Whitley, R.J.2
-
11
-
-
21144448596
-
A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults
-
Oxman M.N., Levin M.J., Johnson G.R., et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 352 (2005) 2271-2284
-
(2005)
N Engl J Med
, vol.352
, pp. 2271-2284
-
-
Oxman, M.N.1
Levin, M.J.2
Johnson, G.R.3
-
12
-
-
19644396081
-
Varicella-zoster virus vaccine-grown-ups need it, too
-
Gilden D.H. Varicella-zoster virus vaccine-grown-ups need it, too. N Engl J Med 352 (2005) 2344-2346
-
(2005)
N Engl J Med
, vol.352
, pp. 2344-2346
-
-
Gilden, D.H.1
-
13
-
-
4644359971
-
Guidelines for immunizations in patients with inflammatory bowel disease
-
Sands B.E., Cuffari C., Katz J., et al. Guidelines for immunizations in patients with inflammatory bowel disease. Inflamm Bowel Dis 10 (2004) 677-692
-
(2004)
Inflamm Bowel Dis
, vol.10
, pp. 677-692
-
-
Sands, B.E.1
Cuffari, C.2
Katz, J.3
-
14
-
-
0033083008
-
Shingles during the course of treatment with 6-mercaptopurine for inflammatory bowel disease
-
Korelitz B.I., Fuller S.R., Warman J.I., et al. Shingles during the course of treatment with 6-mercaptopurine for inflammatory bowel disease. Am J Gastroenterol 94 (1999) 424-426
-
(1999)
Am J Gastroenterol
, vol.94
, pp. 424-426
-
-
Korelitz, B.I.1
Fuller, S.R.2
Warman, J.I.3
-
15
-
-
0036278519
-
The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review
-
Fraser A.G., Orchard T.R., and Jewell D.P. The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review. Gut 50 (2002) 485-489
-
(2002)
Gut
, vol.50
, pp. 485-489
-
-
Fraser, A.G.1
Orchard, T.R.2
Jewell, D.P.3
-
16
-
-
0024457688
-
6-Mercaptopurine in the management of inflammatory bowel disease: short- and long-term toxicity
-
Present D.H., Meltzer S.J., Krumholz M.P., et al. 6-Mercaptopurine in the management of inflammatory bowel disease: short- and long-term toxicity. Ann Intern Med 111 (1989) 641-649
-
(1989)
Ann Intern Med
, vol.111
, pp. 641-649
-
-
Present, D.H.1
Meltzer, S.J.2
Krumholz, M.P.3
-
17
-
-
24144479466
-
Increased risk for demyelinating diseases in patients with inflammatory bowel disease
-
Gupta G., Gelfand J.M., and Lewis J.D. Increased risk for demyelinating diseases in patients with inflammatory bowel disease. Gastroenterology 129 (2005) 819-826
-
(2005)
Gastroenterology
, vol.129
, pp. 819-826
-
-
Gupta, G.1
Gelfand, J.M.2
Lewis, J.D.3
-
18
-
-
1542287344
-
Seasonal variation in flares of inflammatory bowel disease
-
Lewis J.D., Aberra F.N., Lichtenstein G.R., et al. Seasonal variation in flares of inflammatory bowel disease. Gastroenterology 126 (2004) 665-673
-
(2004)
Gastroenterology
, vol.126
, pp. 665-673
-
-
Lewis, J.D.1
Aberra, F.N.2
Lichtenstein, G.R.3
-
19
-
-
22244445162
-
The relationship between time since registration and measured incidence rates in the General Practice Research Database
-
Lewis J.D., Bilker W.B., Weinstein R.B., et al. The relationship between time since registration and measured incidence rates in the General Practice Research Database. Pharmacoepidemiol Drug Saf 14 (2005) 443-451
-
(2005)
Pharmacoepidemiol Drug Saf
, vol.14
, pp. 443-451
-
-
Lewis, J.D.1
Bilker, W.B.2
Weinstein, R.B.3
-
20
-
-
0036001098
-
Validity and completeness of the General Practice Research Database for studies of inflammatory bowel disease
-
Lewis J.D., Brensinger C., Bilker W.B., et al. Validity and completeness of the General Practice Research Database for studies of inflammatory bowel disease. Pharmacoepidemiol Drug Saf 11 (2002) 211-218
-
(2002)
Pharmacoepidemiol Drug Saf
, vol.11
, pp. 211-218
-
-
Lewis, J.D.1
Brensinger, C.2
Bilker, W.B.3
-
22
-
-
0028938053
-
The VAMP Research multi-purpose database in the U.K.
-
Lis Y., and Mann R.D. The VAMP Research multi-purpose database in the U.K. J Clin Epidemiol 48 (1995) 431-443
-
(1995)
J Clin Epidemiol
, vol.48
, pp. 431-443
-
-
Lis, Y.1
Mann, R.D.2
-
23
-
-
7144259074
-
Use of the UK General Practice Research Database for pharmacoepidemiology
-
Garcia Rodriguez L.A., and Perez Gutthann S. Use of the UK General Practice Research Database for pharmacoepidemiology. Br J Clin Pharmacol 45 (1998) 419-425
-
(1998)
Br J Clin Pharmacol
, vol.45
, pp. 419-425
-
-
Garcia Rodriguez, L.A.1
Perez Gutthann, S.2
-
24
-
-
0025856399
-
Validation of information recorded on general practitioner based computerised data resource in the United Kingdom
-
Jick H., Jick S.S., and Derby L.E. Validation of information recorded on general practitioner based computerised data resource in the United Kingdom. BMJ 302 (1991) 766-768
-
(1991)
BMJ
, vol.302
, pp. 766-768
-
-
Jick, H.1
Jick, S.S.2
Derby, L.E.3
-
26
-
-
0034764110
-
Inflammatory bowel disease is not associated with an increased risk of lymphoma
-
Lewis J.D., Bilker W.B., Brensinger C., et al. Inflammatory bowel disease is not associated with an increased risk of lymphoma. Gastroenterology 121 (2001) 1080-1087
-
(2001)
Gastroenterology
, vol.121
, pp. 1080-1087
-
-
Lewis, J.D.1
Bilker, W.B.2
Brensinger, C.3
-
27
-
-
0034075584
-
Azathioprine for maintenance of remission in Crohn's disease: benefits outweigh the risk of lymphoma
-
Lewis J.D., Schwartz J.S., and Lichtenstein G.R. Azathioprine for maintenance of remission in Crohn's disease: benefits outweigh the risk of lymphoma. Gastroenterology 118 (2000) 1018-1024
-
(2000)
Gastroenterology
, vol.118
, pp. 1018-1024
-
-
Lewis, J.D.1
Schwartz, J.S.2
Lichtenstein, G.R.3
-
28
-
-
0002440652
-
Case-control studies
-
Rothman K.J., and Greenland S. (Eds), Lippincott-Raven, Philadelphia, PA
-
Rothman K.J., and Greenland S. Case-control studies. In: Rothman K.J., and Greenland S. (Eds). Modern epidemiology. 2nd ed. (1998), Lippincott-Raven, Philadelphia, PA 98
-
(1998)
Modern epidemiology. 2nd ed.
, pp. 98
-
-
Rothman, K.J.1
Greenland, S.2
-
29
-
-
0031791398
-
Cellular immunity to varicella-zoster virus in patients with major depression
-
Irwin M., Costlow C., Williams H., et al. Cellular immunity to varicella-zoster virus in patients with major depression. J Infect Dis 178 Suppl 1 (1998) S104-S108
-
(1998)
J Infect Dis
, vol.178
, Issue.SUPPL. 1
-
-
Irwin, M.1
Costlow, C.2
Williams, H.3
-
30
-
-
0347987043
-
What does epidemiology tell us about risk factors for herpes zoster?
-
Thomas S.L., and Hall A.J. What does epidemiology tell us about risk factors for herpes zoster?. Lancet Infect Dis 4 (2004) 26-33
-
(2004)
Lancet Infect Dis
, vol.4
, pp. 26-33
-
-
Thomas, S.L.1
Hall, A.J.2
-
31
-
-
0003591684
-
-
HM Stationery Office, London
-
McCormick A., and Charlton J. Morbidity statistics from general practice: 4th national study 1991-92. A study carried out by the Royal College of General Practitioners, the Office of Population Censuses and Surveys, and the Department of Health (1995), HM Stationery Office, London
-
(1995)
Morbidity statistics from general practice: 4th national study 1991-92. A study carried out by the Royal College of General Practitioners, the Office of Population Censuses and Surveys, and the Department of Health
-
-
McCormick, A.1
Charlton, J.2
-
32
-
-
0031828907
-
Race and stress in the incidence of herpes zoster in older adults
-
Schmader K., George L.K., Burchett B.M., et al. Race and stress in the incidence of herpes zoster in older adults. J Am Geriatr Soc 46 (1998) 973-977
-
(1998)
J Am Geriatr Soc
, vol.46
, pp. 973-977
-
-
Schmader, K.1
George, L.K.2
Burchett, B.M.3
-
33
-
-
0037401604
-
Epidemiology of Varicella-Zoster virus in England and Wales
-
Brisson M., and Edmunds W.J. Epidemiology of Varicella-Zoster virus in England and Wales. J Med Virol 70 Suppl 1 (2003) S9-S14
-
(2003)
J Med Virol
, vol.70
, Issue.SUPPL. 1
-
-
Brisson, M.1
Edmunds, W.J.2
-
34
-
-
3042833447
-
Overview of the actions of glucocorticoids on the immune response: a good model to characterize new pathways of immunosuppression for new treatment strategies
-
Franchimont D. Overview of the actions of glucocorticoids on the immune response: a good model to characterize new pathways of immunosuppression for new treatment strategies. Ann N Y Acad Sci 1024 (2004) 124-137
-
(2004)
Ann N Y Acad Sci
, vol.1024
, pp. 124-137
-
-
Franchimont, D.1
-
35
-
-
1642564175
-
Drug immunosuppression therapy for adult heart transplantation. Part 1: immune response to allograft and mechanism of action of immunosuppressants
-
Mueller X.M. Drug immunosuppression therapy for adult heart transplantation. Part 1: immune response to allograft and mechanism of action of immunosuppressants. Ann Thorac Surg 77 (2004) 354-362
-
(2004)
Ann Thorac Surg
, vol.77
, pp. 354-362
-
-
Mueller, X.M.1
-
36
-
-
0037458439
-
Molecular mechanisms of corticosteroid actions in chronic inflammatory airway diseases
-
Pelaia G., Vatrella A., Cuda G., et al. Molecular mechanisms of corticosteroid actions in chronic inflammatory airway diseases. Life Sci 72 (2003) 1549-1561
-
(2003)
Life Sci
, vol.72
, pp. 1549-1561
-
-
Pelaia, G.1
Vatrella, A.2
Cuda, G.3
-
37
-
-
0037282538
-
Azathioprine and anti-TNF alpha therapies in Crohn's disease: a review of pharmacology, clinical efficacy and safety
-
Arnott I.D., Watts D., and Satsangi J. Azathioprine and anti-TNF alpha therapies in Crohn's disease: a review of pharmacology, clinical efficacy and safety. Pharmacol Res 47 (2003) 1-10
-
(2003)
Pharmacol Res
, vol.47
, pp. 1-10
-
-
Arnott, I.D.1
Watts, D.2
Satsangi, J.3
-
38
-
-
0024762524
-
Risk of infectious complications in patients taking glucocorticosteroids
-
Stuck A.E., Minder C.E., and Frey F.J. Risk of infectious complications in patients taking glucocorticosteroids. Rev Infect Dis 11 (1989) 954-963
-
(1989)
Rev Infect Dis
, vol.11
, pp. 954-963
-
-
Stuck, A.E.1
Minder, C.E.2
Frey, F.J.3
-
39
-
-
0025060990
-
Immunization of children with acute lymphoblastic leukemia with live attenuated varicella vaccine without complete suspension of chemotherapy
-
Arbeter A.M., Granowetter L., Starr S.E., et al. Immunization of children with acute lymphoblastic leukemia with live attenuated varicella vaccine without complete suspension of chemotherapy. Pediatrics 85 (1990) 338-344
-
(1990)
Pediatrics
, vol.85
, pp. 338-344
-
-
Arbeter, A.M.1
Granowetter, L.2
Starr, S.E.3
-
40
-
-
0022252829
-
Clinical experience with Oka live varicella vaccine in Japan
-
Takahashi M., Kamiya H., Baba K., et al. Clinical experience with Oka live varicella vaccine in Japan. Postgrad Med J 61 Suppl 4 (1985) 61-67
-
(1985)
Postgrad Med J
, vol.61
, Issue.SUPPL. 4
, pp. 61-67
-
-
Takahashi, M.1
Kamiya, H.2
Baba, K.3
-
41
-
-
0036091078
-
Geriatric drug therapy and healthcare utilization in the United Kingdom
-
Kennerfalk A., Ruigomez A., Wallander M.A., et al. Geriatric drug therapy and healthcare utilization in the United Kingdom. Ann Pharmacother 36 (2002) 797-803
-
(2002)
Ann Pharmacother
, vol.36
, pp. 797-803
-
-
Kennerfalk, A.1
Ruigomez, A.2
Wallander, M.A.3
|